Ambrosino D M
Dana-Farber Cancer Institute, Boston, MA 02115.
Bone Marrow Transplant. 1991;7 Suppl 3:48-51.
Bone marrow transplant patients are at increased risk for pneumococcal and H. influenzae type b (HIB) infections. These polysaccharide encapsulated bacteria are also pathogens for young healthy children. In healthy children age related susceptibility has been associated with poor response to polysaccharides and low serum IgG2 subclass antibody concentrations. Of note, immune reconstitution following bone marrow transplantation has been characterized by slow return of both the response to polysaccharides and IgG2 serum concentrations. Thus immune reconstitution following bone marrow transplantation is similar to the maturation that occurs in healthy children. In addition to transplant patients, we have identified five groups of immunodeficient patients who are at increased risk for polysaccharide encapsulated pathogens. IgG2 subclass deficient patients were shown to have impaired responses to polysaccharide antigens. We have also defined "Selective Antibody Deficiencies" which are individuals with normal IgG subclass concentrations but poor responses to polysaccharide antigens. Next, patients who developed HIB disease in spite of immunization (i.e. HIB vaccine failures) were demonstrated to have lower serum IgG2 and IgG4 subclass concentrations compared to controls. Finally, Native Americans (an ethnic group with an increased incidence of pneumococcal and HIB infections) were shown to be poor responders to polysaccharide antigens and have significantly lower concentrations of serum IgG2 and IgG4 as compared to controls. New HIB polysaccharide vaccines linked to protein antigens (conjugate vaccines) have been developed that are more immunogenic in healthy young children. In addition, these conjugate vaccines have resulted in protective responses in each of the newly described immunodeficient groups. We therefore now propose to evaluate bone marrow transplant patients' response to HIB conjugate vaccine.(ABSTRACT TRUNCATED AT 250 WORDS)
骨髓移植患者感染肺炎球菌和b型流感嗜血杆菌(HIB)的风险增加。这些多糖包膜细菌也是健康幼儿的病原体。在健康儿童中,年龄相关易感性与对多糖的反应不佳和血清IgG2亚类抗体浓度低有关。值得注意的是,骨髓移植后的免疫重建表现为对多糖的反应和IgG2血清浓度恢复缓慢。因此,骨髓移植后的免疫重建类似于健康儿童发生的成熟过程。除了移植患者,我们还确定了五组免疫缺陷患者,他们感染多糖包膜病原体的风险增加。IgG2亚类缺陷患者对多糖抗原的反应受损。我们还定义了“选择性抗体缺陷”,即IgG亚类浓度正常但对多糖抗原反应不佳的个体。其次,尽管接种了疫苗仍发生HIB疾病的患者(即HIB疫苗接种失败)与对照组相比,血清IgG2和IgG4亚类浓度较低。最后,美洲原住民(肺炎球菌和HIB感染发病率增加的一个种族群体)对多糖抗原反应不佳,与对照组相比,血清IgG2和IgG4浓度显著较低。已开发出与蛋白质抗原连接的新型HIB多糖疫苗(结合疫苗),在健康幼儿中更具免疫原性。此外,这些结合疫苗在每个新描述的免疫缺陷组中都产生了保护性反应。因此,我们现在提议评估骨髓移植患者对HIB结合疫苗的反应。(摘要截短于250字)